Physician profile
Lisa M Wright
NPI 1700825858
$967.23
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $426 · 2023: $22.57 · 2024: $14.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $261.88 | 2019-2020 | |
| Pfizer INC. | $131.85 | 2019-2020 | |
| Amarin Pharma, INC. | $115.02 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $107.25 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $101.08 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.06 | 2019-2020 | |
| Astellas Pharma US INC | $31.85 | 2020 | |
| Lilly USA, LLC | $27.44 | 2020-2024 | Trulicity, Mounjaro |
| Novo Nordisk INC | $25.04 | 2019-2020 | |
| Medline Industries LP | $22.57 | 2023 | |
| Hologic Sales and Service, LLC | $21.87 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.20 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.38 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.73 | 2019 | |
| Allergan, INC. | $12.49 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.05 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.